Table 3

Causes of DRPs in T2DM patients with hypertension (nā€‰=ā€‰336)
Code Causes* Number of problem (Percentage, %)
C1 Drug/Dose selection 158 (47.0)
C1.1 Inappropriate drug selection 70 (20.8)
C1.2 Inappropriate dosage selection 58 (17.2)
C1.5 Synergistic/preventive drug required and not given 15 (4.5)
C1.8 Manifest side effect, no other cause 15 (4.5)
C2 Drug use process 36 (10.7)
C2.1 Inappropriate timing of administration and/or dosing intervals 2 (0.6)
C2.2 Drug underused/under-administered 33 (9.8)
C2.6 Patient unable to use drug/form as directed 1 (0.3)
C3 Information 13 (3.9)
C3.1 Instructions for use/taking not known 1 (0.3)
C3.2 Patient unaware of reason for drug treatment 6 (1.8)
C3.4 Patient unable to understand local language 6 (1.8)
C4 Patient/Psychological 124 (36.9)
C4.1 Patient forgets to use/take drug 14 (4.2)
C4.2 Patient has concerns with drugs 4 (1.2)
C4.3 Patient suspects side-effect 10 (3.0)
C4.5 Patient unwilling to bother physician 6 (1.8)
C4.7 Patient unwilling to adapt life-style 28 (8.3)
C4.8 Burden of therapy 47 (14.0)
C4.9 Treatment not in line with health beliefs 15 (4.4)
C5 Logistic 5 (1.5)
C5.1 Prescribed drug not available (anymore) 3 (0.9)
C5.2 Prescribing error (only in case of slip of the pen) 2.(0.6)

*Only causes that have frequency of more than one were included.

Zaman Huri and Fun Wee

Zaman Huri and Fun Wee BMC Endocrine Disorders 2013 13:2   doi:10.1186/1472-6823-13-2

Open Data